Pzena Investment Management Portfolio holdings
AUM
$30.8B
1-Year Est. Return
10.1%
1 Year Est. Return
+10.1%
AUM
$28.6B
AUM Growth
-$746M
(-2.5%)
Holding
163
Top Buys
| 1 | +$215M | |
| 2 | +$138M | |
| 3 | +$108M | |
| 4 |
Baxter International
BAX
|
+$107M |
| 5 |
PPG Industries
PPG
|
+$105M |
Top Sells
| 1 | +$429M | |
| 2 | +$428M | |
| 3 | +$287M | |
| 4 |
CVS Health
CVS
|
+$131M |
| 5 |
Equitable Holdings
EQH
|
+$119M |
Sector Composition
| 1 | Financials | 22.65% |
| 2 | Healthcare | 21.54% |
| 3 | Technology | 17.06% |
| 4 | Consumer Discretionary | 11.41% |
| 5 | Consumer Staples | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
CEMIG Preferred Shares
CIG
$5.69B
| $2.79M | 0.01% |
1,583,394
|
|
||
127
KB Financial Group
KB
$29.4B
| $2.72M | 0.01% |
50,351
+11,410
|
|
||
128
Petrobras Class A
PBR.A
$71B
| $2.51M | 0.01% |
192,762
|
|
||
129
Itaú Unibanco
ITUB
$74.6B
| $2.25M | 0.01% |
408,895
-3
|
|
||
130
HSBC
HSBC
$225B
| $1.02M | ﹤0.01% |
17,777
-473
|
|
||
131
ING
ING
$70.2B
| $989K | ﹤0.01% |
50,477
-4,063
|
|
||
132
ArcelorMittal
MT
$29.2B
| $975K | ﹤0.01% |
33,810
-2,236
|
|
||
133
Barclays
BCS
$67.5B
| $911K | ﹤0.01% |
59,296
-26,930
|
|
||
134
ICICI Bank
IBN
$117B
| $616K | ﹤0.01% |
19,541
-55,286
|
|
||
135
NatWest
NWG
$57.7B
| $526K | ﹤0.01% |
44,098
-9,484
|
|
||
136
Philips
PHG
$27B
| $399K | ﹤0.01% |
16,376
+2,114
|
|
||
137
Sumitomo Mitsui Financial
SMFG
$101B
| $342K | ﹤0.01% |
22,134
+2,515
|
|
||
138
Sanofi
SNY
$123B
| $299K | ﹤0.01% |
+5,385
|
|
||
139
Gilead Sciences
GILD
$153B
| $298K | ﹤0.01% |
2,662
-561
|
|
||
140
Intel
INTC
$177B
| $280K | ﹤0.01% |
+12,326
|
|
||
141
Cencora
COR
$62.3B
| $273K | ﹤0.01% |
980
-224
|
|
||
142
eBay
EBAY
$42.5B
| $261K | ﹤0.01% |
+3,860
|
|
||
143
Walt Disney
DIS
$199B
| $251K | ﹤0.01% |
2,544
-3,962
|
|
||
|
DFS
144
DELISTED
Discover Financial Services
DFS
| $249K | ﹤0.01% |
+1,459
|
|
||
145
Equinor
EQNR
$58B
| $246K | ﹤0.01% |
+9,300
|
|
||
146
Cirrus Logic
CRUS
$6.41B
| $232K | ﹤0.01% |
+2,327
|
|
||
147
AbbVie
ABBV
$406B
| – | – |
-1,670
|
|
||
148
Amgen
AMGN
$160B
| – | – |
-803
|
|
||
149
AXIS Capital
AXS
$7.22B
| – | – |
-225,236
|
|
||
150
Belden
BDC
$4.43B
| – | – |
-4,378
|
|